Where inositol is permitted, and what the file must show
In the EU, myo-inositol is used as a food ingredient in food supplements rather than as a listed vitamin or mineral, so the vitamin and mineral positive list is not the route and national rules still need checking. In the US it is sold as a dietary ingredient, and in the UK it is a food ingredient under retained food law. In all three, contaminant limits, the label and claims are separate checks.
Permission, contaminant limits, label wording and claims are four separate checks, and no single certificate answers all four.
Three markets, three routes
The EU regulates food supplements through Directive 2002/46/EC and general food law; the US through DSHEA and 21 CFR 111; the UK through retained food law and its own supplement regulations. The routes share a concern for safety, composition and honest labelling, but they do not use the same permission list or label panel.
This page is a sourcing reference, not legal advice, reflecting the position at this review. Regulations change, so the current text named for each market is the reference for a live project.
The EU position
Myo-inositol is not a vitamin in Annex I to Directive 2002/46/EC, and it is not one of the vitamin or mineral forms in Annex II. That means the positive-list route for vitamins and minerals does not describe it; it is used as a food ingredient in food supplements, and the supplement rules still apply to the finished product. The label carries the “food supplement” descriptor, the ingredient list, the amount per portion, the supplement warnings and the general food information rules.
Because inositol is not a vitamin or mineral with a nutrient reference value, the label does not carry a percentage NRV for it. That is a common labelling error: a %NRV figure implies a vitamin or mineral status the ingredient does not have. The nutrition declaration still applies to the product as a food.
Member State rules vary. Some countries require a notification or registration before a supplement is placed on the market, and national maximum levels or guidance can be stricter than the EU framework. The novel-food status of the ingredient should also be documented for the destination. Myo-inositol has a long history of food use, but the operator should confirm the current novel-food catalogue and the national position rather than rely on a generic statement.
On claims, Regulation (EU) No 432/2012 authorises health claims for named nutrients, and there is no authorised claim for inositol. Only authorised claims may be used, so a disease-related claim or an implied one is outside the framework.
The US position
Myo-inositol is sold as a dietary ingredient. In the Supplement Facts panel it is declared by name and amount per serving, with “Daily Value not established” because no Daily Value has been set for inositol. The source form sits in the ingredient list; for a 40:1 blend, both myo-inositol and D-chiro-inositol should be named.
Dietary supplements do not require premarket approval of the ingredient or the label, but the manufacturer must follow the cGMP rule, keep batch records and report serious adverse events. A dietary ingredient that was not marketed in the US before 15 October 1994 is a new dietary ingredient and needs a premarket notification; the brand should confirm the status of its ingredient.
Structure or function claims are permitted with the required disclaimer, and they must be truthful and substantiated. Disease claims are not. California Proposition 65 adds a separate exposure calculation and warning duty for listed substances, including lead, and it applies alongside the federal framework.
The UK position
Great Britain applies retained EU-era food law through the Food Supplements (England) Regulations 2003 and their devolved equivalents, together with retained contaminant and labelling rules. Myo-inositol is used as a food ingredient, the supplement particulars apply, and there is no NRV for inositol. Northern Ireland applies EU rules under the Windsor Framework, so a pack for Belfast and a pack for Glasgow can face different routes.
Retained law can diverge from the EU; check the current text for the relevant nation before the label is finalised.
Contaminant limits
The limits below are those in force at this review.
| Parameter | EU food supplement limit | Catalog specification | UK |
|---|---|---|---|
| Lead (Pb) | 3.0 mg/kg | ≤3 mg/kg | Retained EU limit |
| Cadmium (Cd) | 1.0 mg/kg; 3.0 mg/kg for seaweed or bivalve-based supplements | ≤1 mg/kg | Retained EU limit |
| Mercury (Hg) | 0.10 mg/kg | ≤0.1 mg/kg | Retained EU limit |
| Arsenic (As) | No harmonised EU maximum for food supplements | ≤2 mg/kg | No harmonised maximum; check guidance |
The EU limits in Regulation (EU) 2023/915 apply to the food supplement as placed on the market, while the catalog specification is a raw-material release limit. A raw material that meets the catalog limit still has to be checked against the finished-product limit at the intended portion. The catalog figure sits at or below the EU limit for lead, cadmium and mercury; for arsenic it sets a supplier limit where the EU has no harmonised maximum.
The US has no federal maximum for these elements in dietary supplements. The brand's specification, USP monographs where they apply, and Proposition 65 are the practical controls. A supplier certificate covers the raw material, not the finished product.
What the label can say
No disease-related claim belongs on an inositol pack. That includes direct, implied and testimonial suggestions of a medical outcome. In the EU, only the health claims authorised in Regulation (EU) No 432/2012 may be used, and inositol has none. In the US, a structure or function statement is permitted with the disclaimer and must be substantiated; in the UK, the retained claim rules follow the same logic.
“Inositol” is not a vitamin, so a %NRV figure is wrong. A 40:1 blend should name both isomers and state the ratio; a front-of-pack ratio statement does not replace the ingredient-list entries. A statement about the blend is a claim and faces the same test.
The file a brand needs
- Batch certificate of analysis, lot-specific, with methods and results.
- Current specification, including the isomer, assay basis and particle size.
- Technical data sheet and safety data sheet.
- Heavy-metal and microbiological reports.
- Allergen and composition statement.
- Country of origin and manufacturing flow chart.
- Novel-food or new-dietary-ingredient status statement for the destination.
The file supports the brand's own assessment; it does not replace it. The operator remains responsible for composition, label and claims.
Buyer checklist
- Is the isomer named, and does the label match the certificate?
- Is the destination route confirmed: EU Member State, UK nation or US?
- Do the contaminant results meet the finished-product limit at the intended portion?
- Is the %NRV omitted for inositol?
- Is every claim authorised or substantiated for that market?
- Is the COA issued for the lot being shipped?
- Is the novel-food or NDI status documented?
- Is any required notification or registration complete?
The market notes for the European Union, United States and United Kingdom set out the instruments in more detail. The specification is on the inositol product page, the label names are compared on the grade page, and the batch parameters are on the COA page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation